<--- Back to Details
First PageDocument Content
Chemistry / Selective serotonin reuptake inhibitors / Neurochemistry / Organic chemistry / Fluoxetine / Sertraline / Antidepressant / Paroxetine / Citalopram / Venlafaxine / Management of depression / Bupropion
Date: 2009-03-02 01:57:58
Chemistry
Selective serotonin reuptake inhibitors
Neurochemistry
Organic chemistry
Fluoxetine
Sertraline
Antidepressant
Paroxetine
Citalopram
Venlafaxine
Management of depression
Bupropion

Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits? Benefits of SSRIs Joel M. Kauffman, Ph.D.

Add to Reading List

Source URL: www.jpands.org

Download Document from Source Website

File Size: 184,38 KB

Share Document on Facebook

Similar Documents

Menopause Publishes Pivotal Trial Results for Brisdelle™ (Paroxetine) Capsules, an FDA-Approved Non-Hormonal Therapy for Vasomotor Symptoms Associated with Menopause Miami, FL and New York, NY, September 18, 2013 – N

Menopause Publishes Pivotal Trial Results for Brisdelle™ (Paroxetine) Capsules, an FDA-Approved Non-Hormonal Therapy for Vasomotor Symptoms Associated with Menopause Miami, FL and New York, NY, September 18, 2013 – N

DocID: 1vh4h - View Document

Noven Enters Co-Promotion Agreement with Shionogi for Brisdelle™ (Paroxetine) Capsules Co-Promotion to Extend Physician Awareness of the First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Menopa

Noven Enters Co-Promotion Agreement with Shionogi for Brisdelle™ (Paroxetine) Capsules Co-Promotion to Extend Physician Awareness of the First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Menopa

DocID: 1uLvr - View Document

Noven Pharmaceuticals Announces Issuance of New U.S. Patent, an Important Addition to its Intellectual Property Portfolio for Brisdelle® (Paroxetine) Capsules, 7.5 mg MIAMI and NEW YORK, March 25, 2014 – Noven Pharmac

Noven Pharmaceuticals Announces Issuance of New U.S. Patent, an Important Addition to its Intellectual Property Portfolio for Brisdelle® (Paroxetine) Capsules, 7.5 mg MIAMI and NEW YORK, March 25, 2014 – Noven Pharmac

DocID: 1tRNZ - View Document

Do not take extra medicine to treat tadalafil super active attention deficit hyperactivity disorder . an antidepressant--citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline. Answers from Donald Hens

Do not take extra medicine to treat tadalafil super active attention deficit hyperactivity disorder . an antidepressant--citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline. Answers from Donald Hens

DocID: 1sM49 - View Document

formulation of paroxetine. paroxetine canadian pharmacy methadone and paroxetine interaction, paroxetine long term side effects manufactuer of paroxetine tablets paroxetine withdrawal paroxetine hcl 25 mg, generic paroxe

formulation of paroxetine. paroxetine canadian pharmacy methadone and paroxetine interaction, paroxetine long term side effects manufactuer of paroxetine tablets paroxetine withdrawal paroxetine hcl 25 mg, generic paroxe

DocID: 1rNxr - View Document